SCI Abstract

search
+
Dupuytren contracture treatments compared
In an open-label clinical trial, collagenase injection was not noninferior to limited fasciectomy for the treatment of Dup...
The management of adult and paediatric uveitis for rheumatologists
The management of adult and paediatric uveitis for rheumatologists
Uveitis encompasses multiple different conditions that are all characterized by intra-ocular inflammation. Uveitis occurs ...
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus
Emerging evidence indicates that memory B cells are dysfunctional in systemic lupus erythematosus (SLE). They are hyporesp...
Publisher Correction: Recent advances in the diagnosis and management of neuropsychiatric lupus
Authors and AffiliationsDivision of Rheumatology, Department of Medicine, Dalhousie University and Queen Elizabeth II Heal...
The emergence of SLE-causing UNC93B1 variants in 2024
During the past year, four studies have reported ten mutations in UNC93B1, which encodes the Toll-like receptor (TLR) chap...
The quest for targetable pain mechanisms in 2024
Studies published in 2024 suggest that although the repurposing of established rheumatology drugs seems to deliver increme...
EULAR and PReS bridge the age gap in Still’s disease
EULAR and PReS bridge the age gap in Still’s disease
EULAR and the Paediatric Rheumatology European Society (PReS) now view systemic juvenile idiopathic arthritis and adult-on...
An update on autoantibodies in the idiopathic inflammatory myopathies
An update on autoantibodies in the idiopathic inflammatory myopathies
Myositis-specific autoantibodies (MSAs) have become pivotal biomarkers for idiopathic inflammatory myopathies and have rev...
Nanoparticle-based pazopanib shows promise in OA
A nanoparticle-based formulation of the anticancer drug pazopanib, which inhibits VEGFR1 and VEGFR2, shows promise as a di...
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups
We thank Giannini et al.1 for their response (Giannini, M. et al. Current classification criteria und...
Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups
We read with great interest the Review article by Khoo et al. (Epidemiology of the idiopathic inflamm...
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk
Rheumatoid arthritis (RA) has an estimated heritability of nearly 50%, which is particularly high in seropositive RA. HLA ...
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, ...
Author Correction: Proposals for the rheumatological use of JAK inhibitors
Authors and AffiliationsUniversity della Campania, Department of Precision Medicine, Naples, ItalyFrancesco CicciaUniversi...
Time for a new approach to drug development for rare systemic autoinflammatory diseases
Despite the transformative potential of treatments for systemic autoinflammatory diseases, these conditions remain underfu...
Author Correction: Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells
Author notesThese authors contributed equally: Christian Jorgensen, Danièle Noël.Authors and AffiliationsIRMB, University ...
Biological and clinical roles of IL-18 in inflammatory diseases
Biological and clinical roles of IL-18 in inflammatory diseases
Several new discoveries have revived interest in the pathogenic potential and possible clinical roles of IL-18. IL-18 is a...
Nanohybrid therapy hits multiple arthritis targets
A novel combination of ceria nanoparticles and mesenchymal stem cell nanovesicles modified both inflammation and autoimmun...
Shifting the SLE management paradigm: challenges and implications
Shifting the SLE management paradigm: challenges and implications
Newly published European guidelines for the management of systemic lupus erythematosus (SLE) and lupus nephritis, specific...
Primary care rheumatology: towards sustainable development in health
Globally, rheumatic musculoskeletal diseases constitute the most common causes of disability, related morbidity and econom...
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (MDA5-DM) is a subtype of derm...
Profiling joint tissues at single-cell resolution: advances and insights
Profiling joint tissues at single-cell resolution: advances and insights
Advances in the profiling of human joint tissues at single-cell resolution have provided unique insights into the organiza...
Targeted NOD2 sequencing uncovers JIA misdiagnosis
New findings support the use of targeted next-generation sequencing of NOD2 to reassess the diagnosis of juvenile idiopath...
Single-cell atlas unveils the diversity of RA synovial tissue
Researchers have conducted a comprehensive single-cell analysis of synovial tissue in rheumatoid arthritis, providing insi...
Multi-omics reveals distinct MPA subtypes
Using multi-omics analyses, researchers have identified two distinct immunological phenotypes of microscopic polyangiitis,...
l-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism
New research shows that the amino acid l-arginine ameliorates arthritis and inhibits inflammatory bone loss by altering en...
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis
Since the original description of spondyloarthritis 50 years ago, results have demonstrated similarities and differences b...
25 years of biologic DMARDs in rheumatology
25 years of biologic DMARDs in rheumatology
2023 marks 25 years since the approval of the first biologic drug in rheumatology. In this Viewpoint, five rheumatology re...
Immune mechanisms of depression in rheumatoid arthritis
Immune mechanisms of depression in rheumatoid arthritis
Depression is a common and disabling comorbidity in rheumatoid arthritis that not only decreases the likelihood of remissi...
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Systemic sclerosis (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease of unknown aetiology, characteri...
Load More
format_indent_increase